Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX822 SARS-CoV-2 Spike (RBD domain) Recombinant Antigen

COVID-19 Spike (RBD domain) Recombinant Antigen expressed in CHO cells, Cat. No. AGX822 is for use in Lateral Flow Assay and ELISA.

AGX822
1 mg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberAGX822
DescriptionSARS-CoV-2 Spike (RBD domain) Recombinant Antigen
Alternate Names
  • COVID-19
  • 2019-nCoV
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
Quality LevelMQ100
Applications
ApplicationCOVID-19 Spike (RBD domain) Recombinant Antigen expressed in CHO cells, Cat. No. AGX822 is for use in Lateral Flow Assay and ELISA.
Key Applications
  • ELISA
  • Immunodiffusion
Application NotesAlternative antigen recommendations are AGX821, AGX823, or AGX824
Biological Information
Immunogenfragment
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
HostHuman Recombinant
Purification MethodColumn Purification
UniProt Number
Molecular Weight30 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AGX822 04061842605941

Documentation

SARS-CoV-2 Spike (RBD domain) Recombinant Antigen SDS

Title

Safety Data Sheet (SDS) 

SARS-CoV-2 Spike (RBD domain) Recombinant Antigen Certificates of Analysis

TitleLot Number
SARS-CoV-2 Spike (RBD domain) - 3586588 3586588
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3597263 3597263
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3714315 3714315
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3726065 3726065
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3753310 3753310
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3771114 3771114
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 3843689 3843689
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - 4030446 4030446
SARS-CoV-2 Spike (RBD domain) Recombinant Antigen - Q3485640 Q3485640